BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen L, Guo L, Zhang W, Li Y, Jiang W, Di X, Ma J, Feng L, Zhang K, Shou J. Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients. Front Oncol 2019;9:504. [PMID: 31263677 DOI: 10.3389/fonc.2019.00504] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Cao C, Kang X, Shang B, Shou J, Shi H, Jiang W, Xie R, Zhang J, Zhang L, Zheng S, Bi X, Li C, Ma J. A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma. Int Braz J Urol 2022;48:784-94. [PMID: 35838503 DOI: 10.1590/S1677-5538.IBJU.2021.0859] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Xie R, Wu J, Shang B, Cao C, Bi X, Shi H, Shou J, Guan Y, Zheng M. Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3204189] [Reference Citation Analysis]
3 Dotse E, Lim KH, Wang M, Wijanarko KJ, Chow KT. An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets. Life 2022;12:323. [DOI: 10.3390/life12020323] [Reference Citation Analysis]
4 Galmiche A, Rak J, Roumenina LT, Saidak Z. Coagulome and the tumor microenvironment: an actionable interplay. Trends Cancer 2022:S2405-8033(21)00261-2. [PMID: 35027336 DOI: 10.1016/j.trecan.2021.12.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
5 Nie Z, Chen M, Gao Y, Huang D, Cao H, Peng Y, Guo N, Zhang S. Regulated Cell Death in Urinary Malignancies. Front Cell Dev Biol 2021;9:789004. [PMID: 34869390 DOI: 10.3389/fcell.2021.789004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Castle J, Blower E, Kirwan CC. Update on the role of circulating tumour cells in cancer-associated thrombosis. Thrombosis Update 2021;5:100066. [DOI: 10.1016/j.tru.2021.100066] [Reference Citation Analysis]
7 Obermayr E, Braicu EI, Polterauer S, Loverix L, Concin N, Woelber L, Mahner S, Sehouli J, Van Gorp T, Vergote I, Zeillinger R, Aust S. Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium. Cancers (Basel) 2021;13:5865. [PMID: 34884980 DOI: 10.3390/cancers13235865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Guan Y, Xu F, Tian J, Gao K, Wan Z, Wang Y, Gao M, Wang Z, Chong T. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma. BMC Cancer 2021;21:826. [PMID: 34271857 DOI: 10.1186/s12885-021-08463-7] [Reference Citation Analysis]
9 Li G, Wei X, Su S, Wang S, Wang W, Wang Y, Meng X, Xia J, Song N, Qin C. Identification of an independent immune-genes prognostic index for renal cell carcinoma. BMC Cancer 2021;21:746. [PMID: 34187413 DOI: 10.1186/s12885-021-08367-6] [Reference Citation Analysis]
10 Wang H, Li X, Huang Q, Panic A, Shen D, Jia W, Zhang F, Fan Y, Gao Y, Gu L, Liu K, Peng C, Chen C, Duan J, Chen J, Wu S, Xuan Y, Wang C, Li H, Ma X, Zhang X, Wang B. Prognostic role of bland thrombus in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombus. Urol Oncol 2021;39:302.e1-7. [PMID: 33678501 DOI: 10.1016/j.urolonc.2021.02.005] [Reference Citation Analysis]
11 Tessier-Cloutier B, Twa DD, Marzban M, Kalina J, Chun HE, Pavey N, Tanweer Z, Katz RL, Lum JJ, Salina D. The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma. J Pathol Clin Res 2021;7:385-96. [PMID: 33665979 DOI: 10.1002/cjp2.204] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Roussel E, Kinget L, Verbiest A, Debruyne PR, Baldewijns M, Van Poppel H, Albersen M, Beuselinck B. C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab. Urol Oncol 2021;39:239.e17-25. [PMID: 33485762 DOI: 10.1016/j.urolonc.2020.12.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kang X, Shi H, Wang D, Xiao Z, Tian J, Bi X, Jiang W, Li C, Ma J, Zheng S, Sun Y, Shou J. Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma. Cancer Manag Res 2020;12:10023-33. [PMID: 33116859 DOI: 10.2147/CMAR.S264400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Shi J, Wang K, Xiong Z, Yuan C, Wang C, Cao Q, Yu H, Meng X, Xie K, Cheng Z, Yang H, Chen K, Zhang X. Impact of inflammation and immunotherapy in renal cell carcinoma. Oncol Lett 2020;20:272. [PMID: 33014151 DOI: 10.3892/ol.2020.12135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhang W, Shen Y, Huang H, Pan S, Jiang J, Chen W, Zhang T, Zhang C, Ni C. A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment. Front Immunol 2020;11:1779. [PMID: 32849640 DOI: 10.3389/fimmu.2020.01779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhu K, Li P, Mo Y, Wang J, Jiang X, Ge J, Huang W, Liu Y, Tang Y, Gong Z, Liao Q, Li X, Li G, Xiong W, Zeng Z, Yu J. Neutrophils: Accomplices in metastasis. Cancer Lett 2020;492:11-20. [PMID: 32745581 DOI: 10.1016/j.canlet.2020.07.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Genna A, Vanwynsberghe AM, Villard AV, Pottier C, Ancel J, Polette M, Gilles C. EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers (Basel) 2020;12:E1632. [PMID: 32575608 DOI: 10.3390/cancers12061632] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
18 Zhang J, Ruan J, Wang W, Lu Y, Wang H, Yu X, Wang H, Teng L. Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer. Cancer Manag Res 2020;12:2767-75. [PMID: 32368151 DOI: 10.2147/CMAR.S246566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Guo L, Bi X, Li Y, Wen L, Zhang W, Jiang W, Ma J, Feng L, Zhang K, Shou J. Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma. J Pathol 2020;251:26-37. [PMID: 32073142 DOI: 10.1002/path.5396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]